Resultats de la cerca - Yasuhiro Funahashi
- Mostrar 1 - 20 resultats de 37
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-... per Junji Matsui, Yasuhiro Funahashi, Toshimitsu Uenaka, Tatsuo Watanabe, Akihiko Tsuruoka, Makoto Asada
Publicat 2008Artigo -
6
-
7
-
8
-
9
-
10
E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis... per Junji Matsui, Yuji Yamamoto, Yasuhiro Funahashi, Akihiko Tsuruoka, Tatsuo Watanabe, Toshiaki WAKABAYASHI, Toshimitsu Uenaka, Makoto Asada
Publicat 2007Artigo -
11
Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells per Zoltán Dezső, Judith Oestreicher, Amy Weaver, Stephanie Santiago, Sergei Agoulnik, Jesse C. Chow, Yoshiya Oda, Yasuhiro Funahashi
Publicat 2014Artigo -
12
Lenvatinib mesilate (LEN) enhanced antitumor activity of a PD-1 blockade agent by potentiating Th1 immune response per Yu Kato, Xiaoyi Bao, S. Macgrath, Kimiyo Tabata, Yusaku Hori, Sho Tachino, M. Matijevici, Yasuhiro Funahashi, Junji Matsui
Publicat 2016Artigo -
13
Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models per Osamu Tohyama, Junji Matsui, Kotaro Kodama, Naoko Hata-Sugi, Takayuki Kimura, Kiyoshi Okamoto, Yukinori Minoshima, Masao Iwata, Yasuhiro Funahashi
Publicat 2014Artigo -
14
-
15
Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization per Kiyoshi Okamoto, Megumi Ikemori‐Kawada, A. Jestel, Konstanze von König, Yasuhiro Funahashi, Tomohiro Matsushima, Akihiko Tsuruoka, Atsushi Inoue, Junji Matsui
Publicat 2014Artigo -
16
Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR–MAPK cascades per Taisuke Hoshi, Saori Watanabe Miyano, Hideki Watanabe, Regina Mikie Kanada Sonobe, Yuki Seki, Etsuko Ohta, K. Nomoto, Junji Matsui, Yasuhiro Funahashi
Publicat 2019Artigo -
17
A Foxo/Notch pathway controls myogenic differentiation and fiber type specification per Tadahiro Kitamura, Yukari Kitamura, Yasuhiro Funahashi, Carrie J. Shawber, Diego H. Castrillón, Ramya Kollipara, Ronald A. DePinho, Jan Kitajewski, Domenico Accili
Publicat 2007Artigo -
18
CRMP‐2 directly binds to cytoplasmic dynein and interferes with its activity per Nariko Arimura, Atsushi Hattori, Toshihide Kimura, Shinichi Nakamuta, Yasuhiro Funahashi, Shinji Hirotsune, Ken’ya Furuta, Takashi Urano, Yoko Y. Toyoshima, Kozo Kaibuchi
Publicat 2009Artigo -
19
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition... per Takeshi Yoshida, Yoichi Ozawa, Takayuki Kimura, Yuki Sato, Galina Kuznetsov, Shan Xu, M. Uesugi, Sergei Agoulnik, Noël Taylor, Yasuhiro Funahashi, Junji Matsui
Publicat 2014Artigo -
20
Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus per Masahiro Matsuki, Yusuke Adachi, Yoichi Ozawa, Takayuki Kimura, Taisuke Hoshi, Kiyoshi Okamoto, Osamu Tohyama, Kaoru Mitsuhashi, Atsumi Yamaguchi, Junji Matsui, Yasuhiro Funahashi
Publicat 2017Artigo
Eines de cerca:
Matèries relacionades
Biology
Cancer research
Medicine
Cell biology
Internal medicine
Cancer
Lenvatinib
Signal transduction
Angiogenesis
Biochemistry
Hepatocellular carcinoma
Receptor
Sorafenib
Pharmacology
VEGF receptors
Oncology
Vascular endothelial growth factor
Neuroscience
Chemistry
Fibroblast growth factor
Genetics
In vitro
Notch signaling pathway
Thyroid cancer
Gene
Receptor tyrosine kinase
Tyrosine kinase
Breast cancer
Chemotherapy
Metastasis